Most of us know someone
who has difficulties taking
their medicine.
We are doing something about it.
Medicines in the form of tablets or capsules come with significant challenges
INCONVENIENCE
25% of the general population and more than 80% of patients with neurological diseases or developmental challenges have difficulties swallowing tablets.
PRIVACY CONCERNS
64 % of HIV patients admit to hide their medicines, and
30 – 40 % of the general population skip or delay medications in the workplace out of privacy concerns).
COUNTERFEITING
20% of all medicines in low- and middle-income countries are sub-par or fake, resulting in $300 billion in wasted expenses.
LACK OF CUSTOM DOSING
Studies have shown that fixed doses have significant adverse effects on patients with different body weight such as children.
LACK OF ACCESS
Due to the high cost of transportation and a lack of cold-chain storage, the availability of essential medicines in high-need areas is only 40% of what it should be.
All of these have SERIOUS CONSEQUENCES
LACK OF ADHERENCE
50% of medications for chronic diseases are not taken as prescribed
INFERIOR TREATMENT OUTCOMES
125,000 deaths and 10% of hospitalizations from non-adherence
COST TO THE HEALTH SYSTEM
Estimated $300 billion in avoidable healthcare costs
Our Solution
Oral Dissolvable Strips (ODS) are superior alternatives to medicines in the form of tablets and capsules or even liquid formulations. ODS are thin, stamp-sized strips in which we embed Active Pharmaceutical Ingredients. When placed on the tongue or on the inside of the cheek, they stick and dissolve, releasing medicines without the need for liquids. ODS increase treatment adherence, enable custom dosing, and they increase patient privacy. Oak Therapeutics has developed superior, proprietary ODS technology with dissolution times from seconds to multiple hours and the highest drug loading capability in the industry, making it an ideal delivery platform for a large number of medications.
Revolutionizing Oral Dissolvable Strips
Highest Drug Loading: Oak Therapeutics has pushed its proprietary technology and is now able to load more than 350mg of Active Pharmaceutical Ingredients on a thin, stamp-sized Oral Dissolvable Strip (ODS), opening up a broad therapeutic window for antibiotics, antivirals and many other medicines.
Precision-controlled release: Oral Dissolvable Strips (ODS) are often known for their rapid dissolution time. Oak Therapeutics' ODS has developed formulations that allow us to adjust the dissolution time of ODS from seconds to slow-release over multiple hours, and we can target delivery and absorption sites.
Custom-Dosing: Oak Therapeutics’ ODS enable custom dosing according to a patient's age or weight. Due to the homogeneous distribution of the Active Pharmaceutical Ingredients in the ODS, they can easily be cut into fractional pieces that reflect the right dose for patients such as small children.
A New Manufacturing Paradigm: Traditional manufacturing of Oral Dissolvable Strips (ODS) is energy-consuming and wasteful. Oak Therapeutics is working on new ways to manufacture ODS via cold extrusion and other methods.
External Validation: Our ODS are the result of rigorous research and testing backed by NIH grants and endorsed by physicians.
Our pipeline of products includes nutraceuticals, Over-the-Counter medicines, and prescription pharmaceuticals:
(Dry Mouth / Xerostomia, early commercialization stage)
Isoniazid-Rifapentine
(TB, advanced pre-clinical studies)
Ibuprofen
(Pain, proof of concept)
Slow-release cough relief
(Cough suppressant, early development)
Abacavir-Lamivudine-Dolutegravir
(HIV, advanced pre-clinical studies)
Cenobamate
(Epilepsy, proof of concept)
Xerorinse
(Anti-Plaque, proof of concept)
Acetaminophen
(Pain, proof of concept)
Amoxicillin
(Infections, proof of concept)